BELLA’S FIRST BIKE RIDE


WE ARE HERE


Two years ago, Bella’s granddad was diagnosed with a life-threatening disease. Now balance has been restored to his life.


At BACHEM, we see oligonucleotides as a novel and emerging class of compounds that can address diseases that were previously considered untreatable. It’s why BACHEM is fully committed to the potential of oligonucleotide- based treatments, to help many more patients like Bella’s granddad.


Part of our journey is to continue pioneering manufacturing technologies to help meet larger patient populations and indications.


Innovation that transforms lives


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53